 Westport, CT, April 07, 2022 GLOBE NEWSWIRE -- BioSig Technologies, Inc. NASDAQ: BSGM BioSig or the Company, a medical technology company commercializing an innovative signal processing platform designed to improve signal fidelity and uncover the full range of ECG and intra-cardiac signals, today announced that Kenneth L. Londoner, Chairman and CEO of BioSig Technologies, will be presenting at NobleCon18 - Noble Capital Markets Eighteenth Annual Investor Conference at the Hard Rock Hotel Casino, Hollywood, Florida on Wednesday, April 20, 2022 at 9:30 AM ET. Conference attendees will also have the opportuntity to meet BioSig management during breakout sessions scheduled for 1:00 PM ET on Wednesday April 20, 2022. 